Its expression is restricted to blood cells and it directly binds to intracellular domains of integrins promoting integrin activation together with talin, another integrin-binding protein.

CRB-601 is a monoclonal antibody targeting latent TGFβ activation-by blocking the integrin αVβ8. Pre-clinical data has demonstrated that CRB-601 overcomes tumor immune exclusion and enhances the ...